GB2084150B - Imidazole derivatives - Google Patents

Imidazole derivatives

Info

Publication number
GB2084150B
GB2084150B GB8128515A GB8128515A GB2084150B GB 2084150 B GB2084150 B GB 2084150B GB 8128515 A GB8128515 A GB 8128515A GB 8128515 A GB8128515 A GB 8128515A GB 2084150 B GB2084150 B GB 2084150B
Authority
GB
United Kingdom
Prior art keywords
imidazole derivatives
imidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8128515A
Other versions
GB2084150A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd, Ono Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Publication of GB2084150A publication Critical patent/GB2084150A/en
Application granted granted Critical
Publication of GB2084150B publication Critical patent/GB2084150B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8128515A 1980-09-22 1981-09-21 Imidazole derivatives Expired GB2084150B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55130643A JPS5756464A (en) 1980-09-22 1980-09-22 Imidazole derivative ahd inhibitor for biosyntesis of thromboxane a2

Publications (2)

Publication Number Publication Date
GB2084150A GB2084150A (en) 1982-04-07
GB2084150B true GB2084150B (en) 1984-07-04

Family

ID=15039148

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8128515A Expired GB2084150B (en) 1980-09-22 1981-09-21 Imidazole derivatives

Country Status (3)

Country Link
JP (1) JPS5756464A (en)
DE (1) DE3137674A1 (en)
GB (1) GB2084150B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034160A (en) * 1983-08-05 1985-02-21 Nippon Saitetsuku Kk Preparation of preservable food
JP3294961B2 (en) * 1993-12-10 2002-06-24 杏林製薬株式会社 Novel imidazole derivative and method for producing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS601312B2 (en) * 1978-02-17 1985-01-14 キツセイ薬品工業株式会社 Novel imidazole derivative
GB2016452B (en) * 1978-02-18 1982-07-21 Kissei Pharmaceutical Imidazole compounds
JPS601313B2 (en) * 1978-02-20 1985-01-14 キツセイ薬品工業株式会社 N↓-(ω↓-carboxyalkyl)imidazole
JPS601311B2 (en) * 1978-02-18 1985-01-14 キツセイ薬品工業株式会社 Novel imidazole carboxylic acid ester derivative
JPS6054307B2 (en) * 1978-06-09 1985-11-29 小野薬品工業株式会社 Imidazole derivative
IT1162310B (en) * 1978-05-02 1987-03-25 Ono Pharmaceutical Co IMIDAZOLE DERIVATIVES AND PROCEDURE TO PRODUCE THEM
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative

Also Published As

Publication number Publication date
DE3137674C2 (en) 1989-12-28
JPS5756464A (en) 1982-04-05
JPS622586B2 (en) 1987-01-20
GB2084150A (en) 1982-04-07
DE3137674A1 (en) 1982-05-19

Similar Documents

Publication Publication Date Title
ZA815633B (en) Imidazole derivatives
GB2080304B (en) Hydantoin derivatives
DE3365778D1 (en) Imidazole derivatives
GB2079283B (en) Imidazolidinone derivatives
ZW1983A1 (en) Imidazole derivatives
GB2067989B (en) Bis-moranoline derivatives
GB2075499B (en) Nonaprenylamine derivatives
GB2088872B (en) 1-benzylimidazole derivatives
DE3272262D1 (en) Imidazole derivatives
GB2095251B (en) Imidazole derivatives
PT73642A (en) Imidazoles
DE3166057D1 (en) Hydantoin derivatives
GB2076815B (en) Aminophenylpyridine derivatives
GB2067993B (en) Imidazole hydrazone derivatives
GB2076395B (en) Nonaprenylamine derivatives
GB2070589B (en) 7a1methoxycephalospin derivatives
GB2074165B (en) Nonaprenylamine derivatives
GB2084150B (en) Imidazole derivatives
GB2086384B (en) New imidazole derivatives
GB2073201B (en) Steroid-spiro-oxathiazolidine derivatives
ZW7281A1 (en) Novel imidazole derivatives
ZA812641B (en) Novel imidazole derivatives
GB2086900B (en) Imidazole derivatives
IE802060L (en) Imidazole derivatives
IE802352L (en) Imidazole derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930921